The independent source for health policy research, polling, and news.
KFF’s policy research provides facts and analysis on a wide range of policy issues and public programs.
KFF designs, conducts and analyzes original public opinion and survey research on Americans’ attitudes, knowledge, and experiences with the health care system to help amplify the public’s voice in major national debates.
KFF Health News is a national newsroom that produces in-depth journalism about health issues and is one of the organization’s core operating programs.
What does AI mean for patients in bed and doctors at the bedside? Host Chip Kahn and guest Dr. Robert Wachter, Chair of the Department of Medicine at the University of California, San Francisco, discuss whether AI will produce a different kind of doctor in the future — a “clinician curator rather than a clinician-diagnostician.” The answer could define the future of medicine and the doctor-patient relationship.
With nearly all states poised to allow anyone at least 16 years old to get a COVID-19 vaccine, this week’s announcement pausing the distribution of the Johnson & Johnson vaccine to investigate a rare side effect is raising questions about whether and how it will affect the public’s eagerness to get vaccinated. A new report summarizes key insights about vaccine confidence, messages and messengers from the KFF COVID-19 Vaccine Monitor project, which has interviewed more…
Drawing on KFF’s Misinformation Pilot Poll, KFF today released three follow-up reports examining exposure to, and belief in, health misinformation among Black adults, Hispanic adults, and rural communities. As with the general public, large shares within each group are uncertain about whether each of 10 false health claims are true or not, describing them as either “probably true” or “probably false.” This uncertainty leaves people vulnerable to misinformation but also provides an opportunity to combat…
In this Axios column Drew Altman writes about the recent attention to Republican vaccine resisters. “Republicans and rural Americans are among the most resistant vaccine holdouts and some strategies are emerging to reach them." But “far from all Republicans are resisters” and “the bigger and quicker payoff will come from prioritizing the more moveable group of 'wait and see' Americans.”
Most adults nationally say they have gotten at least one dose of a COVID-19 vaccine, and few say they haven’t but want to do so right away, posing a new challenge for the nation’s vaccination efforts. The latest report also explores parents' intentions for their kids, confidence in vaccines' safety, and a variety of potential incentives and requirements to increase vaccination uptake.
As the vaccine rollout continues across the country, a key question is whether and how far governments and employers can go to require the public and workers to get vaccinated. Our new issue brief explains the legal basis for vaccine mandates and what limitations might apply.
This report shows about half over the age of 65 say they have already received at least one dose of the vaccine or have scheduled an appointment to do so. It also examines how easy or difficult it has been for people to get an appointment and information about the vaccine, and where the public would most like to receive it.
This policy watch highlights a change coming to the Medicare Part D drug benefit that will cap Part D enrollees' out-of-pocket drug costs, beginning in 2024, resulting in savings of thousands of dollars for high-cost drugs - a change that recent KFF tracking poll results show few older adults know about.
This brief examines the two presidential candidates’ records and other recent policy proposals that could inform starkly different directions for the program across key areas, including Affordable Care Act (ACA) Medicaid expansion, financing, eligibility, benefits, and cost-sharing, prescription drugs, long-term services and supports, and managed care.
As we mark three years since the WHO characterized COVID-19 as a pandemic, here are 10 key data points that illuminate the challenges, and progress, made to date.
© 2026 KFF